Company / Operating Income per Share
Tvardi Therapeutics, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$19.28
FY2024
5-year range
-$19.28 / $0.10
FY2020-FY2024
Trend
-1064.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -1064% YoY in FY2024, a notable deviation from the 9-year average annual change of -1016%.
Based on SEC 10-K filings.
-19.28 in FY2024.
Declined from $0.10 to $-19.28 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share decreased 1064.4% year-over-year.
- Peak operating income per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$19.28 | -1064.4% |
| FY2023 | -$1.66 | -1744.5% |
| FY2022 | $0.10 | +104.5% |
| FY2021 | -$2.24 | -35.2% |
| FY2020 | -$1.66 | -10.1% |
| FY2019 | -$1.50 | +15.9% |
| FY2018 | -$1.79 | -93.8% |
| FY2017 | -$0.92 | -39.2% |
| FY2016 | -$0.66 | -6279.5% |
| FY2015 | -$0.01 | +99.3% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026